Dr RR Baliga's "Got Knowledge Doc" Podkast
Oct 14, 2026 · 2 min · 4 segments
🦵 PAD is not simply a disease of the legs—it is systemic atherosclerosis with profound cardiovascular and human consequences. 📊 Symptomatic PAD: 62.5% 5-year all-cause mortality. 🌍 >316 million…
Ragavendra R. BaligaHostThis video is on a Lancet editorial titled "Peripheral Arterial Disease: Counting What Matters." It was published on October third, uh, about a week ago, and there were accompanying three articles on peripheral vascular disease.
The five-year mortality in symptomatic peripheral arterial disease is sixty-two point five percent.
Over three hundred and sixteen million adults were living with peripheral arterial disease in twenty twenty-three.
PAD is a manifestation of systemic atherosclerosis, not a benign local disorder.
It encourages us to treat what matters, including smoking cessation, exercise, risk factor control, and preventive therapy.
It encourages us to count lived outcomes, including mobility, pain, independence, and mental health, not only patency or amputation.
Screening looks possible, but the outcome benefit has not yet been proven in an appropriately designed trial.
The key takeaway in peripheral arterial disease, count cardiovascular risk and how the patient lives.
This video is on a Lancet editorial titled "Peripheral Arterial Disease: Counting What Matters." It was published on October third, uh, about a week ago, and there were accompanying three articles on peripheral vascular disease.
The five-year mortality in symptomatic peripheral arterial disease is sixty-two point five percent.
Over three hundred and sixteen million adults were living with peripheral arterial disease in twenty twenty-three.
PAD is a manifestation of systemic atherosclerosis, not a benign local disorder.
It encourages us to treat what matters, including smoking cessation, exercise, risk factor control, and preventive therapy.
It encourages us to count lived outcomes, including mobility, pain, independence, and mental health, not only patency or amputation.
Screening looks possible, but the outcome benefit has not yet been proven in an appropriately designed trial.
The key takeaway in peripheral arterial disease, count cardiovascular risk and how the patient lives.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.
